EULAV Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

EULAV Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-21,700	Closed	-$895K	–	334
2015 Q2	$895K	Buy	21,700 +14,000	+182%	+$502K	0.05%	282
2015 Q1	$271K	Sell	7,700 -2,600	-25%	-$88K	0.01%	318
2014 Q4	$331K	Sell	10,300 -3,900	-27%	-$113K	0.02%	325
2014 Q3	$398K	Hold	14,200	–	–	0.02%	336
2014 Q2	$429K	Sell	14,200 -3,000	-17%	-$82.8K	0.02%	364
2014 Q1	$476K	Hold	17,200	–	–	0.03%	361
2013 Q4	$439K	Hold	17,200	–	–	0.02%	375
2013 Q3	$514K	Hold	17,200	–	–	0.03%	375
2013 Q2	$494K	Buy	+17,200	New	+$474K	0.03%	370

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

EULAV Asset Management's BRLI Position: Q3 2015 in Review

EULAV Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 21,700 shares — an estimated $895K sold.

EULAV Asset Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $895K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

EULAV Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
EULAV Asset Management sold 21,700 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $895K.
EULAV Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
EULAV Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $895K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on EULAV Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.